Earnings call transcript: Heidelberg reports mixed Q4 2025/26 results

Heidelberg reported FY2025/26 net sales of €2.293 billion, slightly below guidance by 2.4% due to currency headwinds, while adjusted EBITDA margin came in at 6.6% versus an 8% target. Net result improved to €15 million and the stock rose 4.22% after the earnings release, but management flagged continued pressure from FX, U.S. customs issues, and geopolitical uncertainty. The company guided to stable sales and a better margin in FY2026/27, with growth supported by packaging, digitalization, and defense-related initiatives.

Analysis

The market is rewarding the company for proof of operating resilience, but the bigger signal is that management is deliberately exchanging near-term margin for a more defensible earnings mix. Currency and customs pressure are masking the underlying improvement: if constant-currency demand is holding and the stock is still rerating on a weak print, that usually means investors are starting to underwrite the strategic pivot rather than the quarter itself. The key second-order effect is that the new business buildout is no longer a “call option” story; it is now a cash absorber that will likely cap near-term FCF and keep headline quality-of-earnings noisy for several quarters.

The most interesting competitive dynamic is that the company is trying to force a portfolio re-rating away from cyclical capital equipment toward software, lifecycle services, and regulated infrastructure/security. That creates a potential valuation wedge versus industrial peers: if the market starts attributing even a modest recurring-revenue multiple to the service/software layer, the equity can rerate without needing much top-line acceleration. The flip side is execution risk — these adjacencies are capital- and attention-intensive, and the cash drag from defense/charging initiatives could cause the market to mark down the core franchise if growth in the legacy segments slows faster than the new businesses scale.

For catalysts, the next 1-2 quarters matter more than the next fiscal year: investors will focus on whether the mix shift actually lifts gross margin and whether order momentum in China offsets Europe/U.S. softness. The contrarian view is that the stock may be too cheap if the market still prices it as a declining machinery vendor, but also too expensive if the new businesses are treated as immediately monetizable. The most likely mistake is to extrapolate a clean break-even trajectory; the better base case is a choppy transition with upside only if management proves the new ventures can scale without a disproportionate hit to cash conversion.

Key Decisions for Investors

• Long 0OC2 on a 3-6 month horizon: buy weakness rather than strength, targeting a rerating as investors price the mix shift; risk/reward is attractive if the market starts assigning even a partial recurring-revenue multiple to lifecycle/software.
• Pair trade: long 0OC2 / short a traditional industrial machinery peer basket over 1-2 quarters, on the thesis that portfolio transformation and defense/automation exposure will decouple valuation from cyclical capex names.
• Avoid chasing the post-earnings bounce; wait for confirmation in the next two quarterly updates that constant-currency growth and margin bridge are holding before adding size. If margins fail to inflect, the downside is a de-rating back to pure-play machinery multiples.
• For higher-risk exposure, use call spreads on 0OC2 with 6-9 month maturity to express upside from strategic rerating while limiting the FCF-drag risk from expansion into defense and charging infrastructure.
• Watch ONDS as a higher-beta expression of the defense optionality embedded in the story; if contract cadence improves, it can validate the market opportunity, but size positions small because the near-term revenue contribution appears immaterial relative to execution risk.